Huntington Ingalls Industries Inc vs 22nd Century Group Inc — how do they compare? Huntington Ingalls Industries Inc trades at $264.8 (market cap $10.44B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Huntington Ingalls Industries Inc is far larger — about 16793.5× 22nd Century Group Inc's market cap, and Huntington Ingalls Industries Inc pays a 2.08% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Huntington Ingalls Industries Inc for 28 Days and 22nd Century Group Inc for 32 Days on average.
| HII | XXII | |
|---|---|---|
Market Cap | $10.44B | $621.67K |
Volume | 440,462 | 45,625 |
Sector | Industrials | Consumer Staples |
52-Week High | $453.73 | $483.00 |
52-Week Low | $257.05 | $0.80 |
Typical Hold Time | 28 Days | 32 Days |
Enterprise Value | $13.37B | -$3.69M |
Dividend Yield | 2.08% | — |
Signals from Pluang's Aura AI — not financial advice
HII trades at $264.80, up 1.58% today, with a bearish technical signal from moving averages. The company shows solid fundamentals with a P/E of 15.78, net income margin of 5.01%, and a $57.3 billion backlog supporting revenue visibility. Recent contract wins, including a $5.1 billion aircraft carrier overhaul and 10 unmanned vessel orders, highlight operational momentum amid consistent earnings beats.
The outlook is supported by strong defense budgets and execution, but risks include project delays and macroeconomic pressures. Analysts are generally positive with a $363.67 consensus target, implying significant upside, though technical indicators suggest near-term caution.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →